Published in

Future Medicine, Regenerative Medicine, 3(16), p. 253-268, 2021

DOI: 10.2217/rme-2020-0140

Links

Tools

Export citation

Search in Google Scholar

Evaluation of institutional readiness at sites within the UK NHS using a novel advanced therapy medicinal product assessment tool

Journal article published in 2021 by Lisa Wotherspoon ORCID, Ruaridh Buchan ORCID, Ewan Morrison, Greg Amatt
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Aim: This paper reports on a study to assess institutional readiness (IR) of UK National Health Service sites that form part of the Northern Alliance Advanced Therapy Treatment Centre to deliver advanced therapy medicinal products (ATMPs). The paper discusses the development of an assessment tool to support self-assessment of IR in healthcare institutions. Methods: The tool utilized criteria developed by clinicians to self-assess IR to deliver four classes of ATMP over a series of time points. Each assessment was independently analyzed and validated by independent expert groups. Results & conclusion: The collated results indicated an overall trend toward IR for all classes of ATMP. The study highlighted areas where IR is evidenced, areas where work is ongoing and areas where further work is required to achieve IR. The study also facilitated validation of the IR assessment tool.